Label: ADAPALENE 0.1% / BENZOYL PEROXIDE 2.5% / CLINDAMYCIN 1% gel

  • Category: HUMAN PRESCRIPTION DRUG LABEL
  • DEA Schedule: None
  • Marketing Status: unapproved drug other

DISCLAIMER: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. For further information about unapproved drugs, click here.

Drug Label Information

Updated June 3, 2020

If you are a consumer or patient please visit this version.

  • Directions for use

    d

  • Sincerus Florida, LLC. Adverse reactions

    x

  • Active and Inactive

    123

  • NDC 72934-1002-2 ADAPALENE USP 0.1% / BENZOYL PEROXIDE USP 2.5% / CLINDAMYCIN USP 1%. Gel 30gm

    s

  • INGREDIENTS AND APPEARANCE
    ADAPALENE 0.1% / BENZOYL PEROXIDE 2.5% / CLINDAMYCIN 1% 
    adapalene 0.1% / benzoyl peroxide 2.5% / clindamycin 1% gel
    Product Information
    Product TypeHUMAN PRESCRIPTION DRUGItem Code (Source)NDC:72934-1002
    Route of AdministrationTOPICAL
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    CLINDAMYCIN PHOSPHATE (UNII: EH6D7113I8) (CLINDAMYCIN - UNII:3U02EL437C) CLINDAMYCIN PHOSPHATE1 g  in 100 g
    ADAPALENE (UNII: 1L4806J2QF) (ADAPALENE - UNII:1L4806J2QF) ADAPALENE0.1 g  in 100 g
    BENZOYL PEROXIDE (UNII: W9WZN9A0GM) (BENZOYL PEROXIDE - UNII:W9WZN9A0GM) BENZOYL PEROXIDE2.5 g  in 100 g
    Product Characteristics
    ColorwhiteScore    
    ShapeSize
    FlavorImprint Code
    Contains    
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:72934-1002-230 g in 1 BOTTLE, PUMP; Type 0: Not a Combination Product05/10/2019
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    unapproved drug other05/10/2019
    Labeler - Sincerus Florida, LLC (080105003)
    Establishment
    NameAddressID/FEIBusiness Operations
    Sincerus Florida, LLC080105003manufacture(72934-1002)